Feed NUVB
NU
Nuvation Bio Inc.
NUVB · NYSE
$6.22 +1.97% (+$0.12)
1M -0.64%
Market Cap $2.2B
P/E Ratio -
Div. Yield -
ROE 61.82%
Bulios Fair Price
$3.51
43.6% downside
Preț actual
$6.22
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile NUVB sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
6 /100
Expensive P/S 34.33x
P/B 7.06x
P/E N/A
Growth
0 /100
Declining Book val. growth 22.43%
EPS growth N/A
Rev. growth N/A
Profitability
20 /100
Weak Gross margin 86.58%
Net margin 325.31%
Op. margin 338.72%
Quality
1 /100
Poor ROIC 40.96%
ROE 61.82%
ROA 34.40%
Debt
69 /100
Low Debt/Equity 0.03x
Current ratio 6.95x
Int. coverage -13.96x
Stability
12 /100
Unstable Beta 1.53x
EPS volatility 319.58%
Profitable years 0
Întreabă StockBot despre NUVB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David T. Hung
Employees
305
Headquarters
New York City
Evenimente viitoare
02 NOV.
Earnings
Upcoming earnings report